Atlas Trials

A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients

Clinical trial NCT05546047 · UNKNOWN

Trial details

NCT number
NCT05546047
Sponsor
NephroNet, Inc.
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Fibrillary Glomerulonephritis
Start date
2019-03-14
Primary completion
2023-10-27
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.